Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_assertion type Assertion NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_head.
- NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_assertion description "[The organ-specific expression of NY-BR-1 and its high prevalence in metastases indicate that it could be a valuable target for cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_provenance.
- NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_assertion evidence source_evidence_literature NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_provenance.
- NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_assertion SIO_000772 16675566 NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_provenance.
- NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_assertion wasDerivedFrom befree-2016 NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_provenance.
- NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_assertion wasGeneratedBy ECO_0000203 NP548257.RA9_cMEYTQ_R1FCGBZIKNrXG91VgKcU7gsm_naNv6I8AY130_provenance.